GKCC LLC 13D and 13G filings for Elicio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-14 5:01 pm Purchase |
2024-08-12 | 13D | Elicio Therapeutics, Inc. ELTX |
GKCC LLC | 5,595,108 38.700% |
3,442,341 (+159.90%) |
Filing |
| 2024-07-02 4:39 pm Purchase |
2024-06-28 | 13D | Elicio Therapeutics, Inc. ELTX |
GKCC LLC | 2,152,767 19.990% |
109,587 (+5.36%) |
Filing |
| 2024-03-20 4:37 pm Purchase |
2024-03-19 | 13D | Elicio Therapeutics, Inc. ELTX |
GKCC LLC | 2,043,180 19.990% |
123,016 (+6.41%) |
Filing |
| 2023-12-26 4:25 pm Purchase |
2023-12-22 | 13D | Elicio Therapeutics, Inc. ELTX |
GKCC LLC | 1,920,164 19.990% |
1,213,000 (+171.53%) |
Filing |
| 2023-06-14 2:42 pm Purchase |
2023-06-01 | 13D | Elicio Therapeutics, Inc. ELTX |
GKCC LLC | 707,164 8.400% |
707,164 (New Position) |
Filing |